See also this year's filing and all EDGAR filings for this company.
PDF Report 0001070336_2016_Achillion_Pharmaceuticals_INC.pdf
Logs
| warning | The EntityCommonStockSharesOutstanding does not exist | industry.us_generic | {} |
| warning | Missing logo | subcommand.report | {} |
Graph
Absolute values for 0001070336, Achillion Pharmaceuticals INC
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 462,588,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 0 |
| 2 | PropertyPlantAndEquipmentNet | 1,735,000 |
| 3 | remainder_Assets | 202,000 |
| 4 | LiabilitiesCurrent | 14,658,000 |
| 5 | LiabilitiesNoncurrent | 231,000 |
| 6 | remainder_Liabilities | 0 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 34,042,333 |
| 9 | ResearchAndDevelopmentExpense | 57,152,865 |
| 10 | remainder_Expenses | 59,774 |
| 11 | remainder_Revenues | 51,582,356 |
| 12 | remainder_NetIncome | 870,588 |
| 13 | remainder_ComprehensiveNetIncome | -28,682 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 464,525,000 |
| 1 | Liabilities | 14,889,000 |
| 2 | Expenses | 91,254,972 |
| 3 | Revenues | 51,582,356 |
| 4 | StockholdersEquity | 449,636,000 |
| 5 | NetIncome | -38,802,028 |
| 6 | ComprehensiveNetIncome | -38,816,369 |
| 7 | BaseVar | 311,575,299 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | 3.93 |
| 9 | EconomicCapitalRatio | 4.34 |
Edgar->Model Mapping
Feature Distribution
Change over Time
